Suchergebnisse - "Zhu, Junmeng"

PubPharm (14)

1

Engineered lactococcus lactis intrapleural therapy promotes regression of malignant pleural effusion by enhancing antitumor immunity

enthalten in: Cancer letters | 2024

von Fan, Y. | Chen, A. | Zhu, J. | +8

2

A Thermosensitive Bi-Adjuvant Hydrogel Triggers Epitope Spreading to Promote the Anti-Tumor Efficacy of Frameshift Neoantigens

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Ke, Y. | Xin, K. | Tao, Y. | +10

3

Intra-bone marrow injection with engineered Lactococcus lactis for the treatment of metastatic tumors : Primary report

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2024

von Liu, R. | Zhu, J. | Chen, A. | +7

4

Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors

enthalten in: Future oncology (London, England) | 2024

von Min, L. | Wang, X. | Chen, A. | +13

5

A Thermosensitive Bi‐Adjuvant Hydrogel Triggers Epitope Spreading to Promote the Anti‐Tumor Efficacy of Frameshift Neoantigens

enthalten in: Advanced Science | 2024

von Ke, Y. | Xin, K. | Tao, Y. | +10

6

Membrane fusogenic nanoparticle-based HLA-peptide-addressing universal T cell receptor-engineered T (HAUL TCR-T) cell therapy in solid tumor

enthalten in: Bioengineering & translational medicine | 2023

von Xu, R. | Wang, Q. | Zhu, J. | +8

7

Enhanced systemic tumor suppression by in situ vaccine combining radiation and OX40 agonist with CpG therapy

enthalten in: Journal of translational medicine | 2023

von Sun, Z. | Chu, Y. | Xiao, J. | +10

8

Enhanced systemic tumor suppression by in situ vaccine combining radiation and OX40 agonist with CpG therapy

enthalten in: Journal of translational medicine | 2023

von Sun, Z. | Chu, Y. | Xiao, J. | +10

9

Enhanced systemic tumor suppression by in situ vaccine combining radiation and OX40 agonist with CpG therapy

enthalten in: Journal of translational medicine | 2023

von Sun, Z. | Chu, Y. | Xiao, J. | +10

10

An open-label single-center investigator-initiated exploratory clinical study in patients with refractory or recurrent solid tumors: ‘R-ISV-FOLactis’ trial

enthalten in: ResearchSquare.com | 2023

von Dai, J. | Wang, X. | Chen, X. | +10